TrakCel is a market leading developer of integrated cell orchestration solutions. TrakCel has specifically designed these solutions to manage the international autologous and allogeneic cell, gene and immunotherapy value and supply chains

Visit website


Its platform has evolved in collaboration with, and is increasingly adopted by, leading companies in the cell, gene and immunotherapy industries. TrakCel’s solutions enable real-time control for all organizations working across the entire therapeutic value chain. This control includes patient eligibility (commercial) and enrolment, sample collection, manufacturing and treatment delivery. The TrakCel platform accelerates global scale-up and scale-out of cell and gene therapy products, increasing efficiency and decreasing complexity, while safe-guarding Chain of Custody and Chain of Identity with a full electronic audit trail for administration compliance and traceability. TrakCel was founded in 2012. It’s headquartered in Cardiff, UK with US offices.

In medicine’s most complex value chain, the successful delivery of advanced therapies presents a unique set of challenges and relies upon a connected, compliant, and scalable value chain. Extended experience in advanced therapy supply chain management meant the founders of TrakCel saw a need for a cell and gene therapy orchestration solution to seamlessly integrate all elements of the supply chain. Ensuring patients are connected to the life saving therapies they need, safely and efficiently with a full audit trail of the whole treatment pathway.

OCELLOS by TrakCel

TrakCel is the first provider of integrated cellular orchestration solutions for the precise management, control and tracking of cell and gene therapy products. With the largest number of live deployments supporting the broadest number of therapy classes in industry, TrakCel has built a deep understanding of the unique challenges faced by advanced therapy developers globally.

OCELLOS by TrakCel is a powerful, integrated cellular orchestration solution for the precise management, control and tracking of advanced therapy supply chains, patient by patient. OCELLOS supports autologous, allogeneic and personalised cancer vaccine therapies at all clinical and commercial stages whilst OCELLOS Lite has been developed for quick, cost-effective deployment for early-stage clinical therapies. Our brand new product OCELLOS Core is an out-of-the-box Chain of Identity and Chain of Custody solution for therapy developers from first in human clinical trials.

TrakCel’s cell orchestration platforms help to establish and safeguard the therapy Chain of Identity and Chain of Custody whilst generating full, reportable, electronic audit trails in real-time for each patient. Dashboards and reports unite therapy developers with healthcare providers and supply chain partners, sharing the information needed to guide decisions and creating alerts and notifications to progress the journey.

TrakCel SaaS cellular orchestration solutions are built on the Salesforce platform and offer visibility, insight and scalability, streamlining the delivery of more therapies, to more patients at their most vulnerable.

Related Content